Citi upgraded L’Oreal SA (EPA: OREP) to a Buy rating, moving it up from Neutral, and increased its price target to €435 from the previous €375. The brokerage now expects the cosmetics group’s organic sales growth to accelerate to a 5.5%‑6.5% range beginning in 2027, compared with its earlier outlook of 4.5%‑5.5%. Citi attributes this stronger outlook to the ongoing integration of Kering Beauty, which includes the Creed fragrance business and the forthcoming Gucci Beauty license; the integration could contribute up to 100 basis points to L’Oreal’s organic sales growth between 2027 and 2030. Accordingly, Citi raised its earnings‑per‑share estimates for 2027‑2029 by roughly 2.4% annually and indicated that the improved growth trajectory could support a re‑rating of the stock’s valuation. The bank also noted that several concerns that have previously weighed on the share price—such as uncertainty surrounding Galderma, SAP‑related reporting changes, and worries over slowing growth—are expected to diminish over time, allowing L’Oreal to outperform peers in the consumer staples sector. Following the upgrade, L’Oreal shares climbed 1.6% to €393.00, marking the highest level since June 15. The article was reported by Roushni Nair.